Hormone receptor profile of apocrine lesions of the breast [1]

Breast Journal

Volumn 9, Issue 4, 2003, Pages 335-336

  Sapp, Michelle ^a   Malik, Abha ^a   Hanna, Wedad ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; TESTOSTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN RETRIEVAL; APOCRINE CARCINOMA; CANCER HORMONE THERAPY; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; METAPLASIA; PHENOTYPE; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, STEROID; SWEAT GLAND NEOPLASMS;

EID: 0043167833     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2003.09422.x     Document Type: Letter

References (5)

1. Wellings SR, Alpers CE. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts. Hum Pathol 1987;18:381-86.
2. Reiner G, Jakesz R, Kolb R, et al. Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors. Dtsch Med Wochenschr 1988;113:892-97.
3. Gatalica Z. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 1997;193:753-58.
4. Sapino A, Righi L, Cassoni P, Pappoti M, Gugliotta P, Bussolati G. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol 2001;14:768-76.
5. Kuenen-Boumeester V, Van der Kwast TH, van Putten WL, Claasen C, van Ooijen B, Henzen-Logmans SC. Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. Int J Cancer 1992;52:581-84.